- Research
- Open access
- Published:
Reliability and repeatability of 2021 ARCO classification and its guiding significance in treatment of nontraumatic osteonecrosis of the femoral head
BMC Musculoskeletal Disorders volume 24, Article number: 469 (2023)
Abstract
Background
The study was designed to evaluate the interobserver reliability and intraobserver repeatability of the 2021 Association Research Circulation Osseous (ARCO) classification and explore its guiding significance in the treatment of nontraumatic osteonecrosis of the femoral head (ONFH).
Methods
In this retrospective study, we randomly selected and investigated 50 sets of preoperative computed tomography or magnetic resonance imaging scans from 96 patients (139 hips) to validate the reliability and repeatability of the 2021 ARCO classification. Patients with a nano-hydroxyapatite/polyamide-66 support rod were included in the clinical efficacy study. The Harris hip score (HHS) was used to assess hip function. Femoral head collapse of > 2 mm was considered radiological failure. Total hip arthroplasty (THA) was performed for clinical failure, and follow-up was discontinued.
Results
The average kappa value of interobserver consistency was 0.652. The average rate of consistency was 90.25%, and the average kappa value of intraobserver consistency was 0.836. Eighty-two patients (122 hips) were enrolled and followed up for a mean of 43.57 ± 9.64 months. There was no significant difference in the HHS among the three groups before surgery, but the difference was statistically significant at the last follow-up. Among them, types 1 and 2 had significantly higher scores at the last follow-up than preoperatively (P < 0.05), whereas type 3 had a lower score at the last follow-up than preoperatively, although the difference was not statistically significant (P > 0.05).According to the imaging evaluation, the failure rate of type 1, 2, and 3 at the last follow-up was 0%, 19%, and 87%, respectively. Univariate analysis showed that the femoral head survival rate of radiography was significantly affected by the new classification system (P = 0.00). At the last follow-up, the incidence rate of THA in type 1, 2, and 3 was 5%, 7%, and 31%, respectively. Univariate analysis showed that the femoral head survival rate was significantly affected by the new classification system (P = 0.001).
Conclusions
The 2021 ARCO classification for early-stage ONFH shows substantial consistency and repeatability. We do not recommend femoral head-preserving surgery for patients with type 3 ONFH.
Backgroud
Osteonecrosis of the femoral head (ONFH) is a potentially devastating disease [1]. If ONFH is not treated promptly and correctly, it often leads to collapse of the femoral head, which in turn leads to osteoarthritis of the hip [2]. ONFH is common in young adults, and its prevalence is reportedly increasing [3]. In addition, because the disease is more common in young people and the prosthesis has a certain lifespan, young patients are at risk of the need for multiple replacements [4]. Therefore, many scholars have focused on how to improve the success rate of preserving the femoral head in patients with early ONFH [5,6,7]. Previous studies have shown that the size and location of lesions are important factors affecting the postoperative outcome of early femoral head necrosis [8,9,10]. Therefore, many studies have attempted to predict the success rate of head preservation surgery in patients with early ONFH by typing the site of the necrotic area [11,12,13,14].
In 2021, Association Research Circulation Osseous (ARCO) developed a novel classification system for early-stage ONFH (types 1, 2, and 3) [15] and currently recommends using this method as a unified classification for early-stage ONFH. The present study was designed to evaluate the interobserver reliability and intraobserver repeatability of the 2021 ARCO classification and explore its guiding significance in the treatment of nontraumatic ONFH.
Materials and methods
This was a retrospective study. All procedures performed were in accordance with the ethical standards of the World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects. All methods were carried out in accordance with the Ethics Committee of Aviation General Hospital (No:HK2019-01-04). A total of 96 patients (139 hips) with early-stage ONFH underwent hip-preserving surgery (single approach to double-channel core decompression and bone grafting with structural bone support) from October 2016 to October 2020 in Aviation General Hospital. All patients underwent preoperative anteroposterior and lateral radiographic examinations, computed tomography (CT), and magnetic resonance imaging (MRI) of both hips.
The 2021 ARCO classification uses two landmarks: the apex of the femoral head and the lateral edge of the acetabulum [15]. When the lateral margin of the necrotic portion is medial to the femoral head apex, the lesion is categorized as type 1 (Fig. 1A) [15]. When the lateral margin is located between the femoral head apex and the lateral acetabular margin, the lesion is categorized as type 2 (Fig. 1B) [15]. When the lateral margin extends outside the lateral acetabular margin, the lesion is categorized as type 3 (Fig. 1C) [15]. Far anterior lesions (Fig. 1D) that do not appear on mid-coronal images (Fig. 1E) are classified as type 1 [15]. Intramedullary infarcts that do not involve the subchondral bone are also classified as type 1 (Fig. 1F) [15]. In cases of necrosis with geometrical shapes, the lateral border of subchondral necrosis is considered the lateral border of necrosis (Fig. 1G), not the lateral border of the necrotic area (Fig. 1H) [15].
We randomly selected and investigated 50 sets of preoperative CT or MRI scans from 96 patients (139 hips) to validate the reliability and repeatability of the 2021 ARCO classification. According to the protocol of the 2021 ARCO classification, eight residents were recruited and trained to independently perform interobserver reliability and intraobserver repeatability evaluations. Additionally, intraobserver repeatability evaluations were conducted again at 2-week intervals by the same group of residents with presentation of the images in a different order.
Details of the surgical procedures (Fig. 1I) are provided in a previously published article [6]. The Harris hip score (HHS) was used to assess hip function. At each follow-up visit, all patients underwent anteroposterior and frog-leg position radiographs of the hip. while radiographs were used to check the depth of the femoral head collapse. Assessment was based on anteroposterior and lateral radiographs, and femoral head collapse of > 2 mm was considered radiological failure. Total hip arthroplasty (THA) was performed for patients with clinical failure, and follow-up was discontinued.
Statistical analysis
SPSS version 22.0 (IBM Corp., Armonk, NY, USA) was used for statistical analysis. Data are expressed as mean ± standard deviation. The kappa coefficient was used to determine reliability and repeatability according to the recommendation by Landis and Koch [16]. Specifically, the kappa value ranged from − 1 to 1, and the results were classified as poor (kappa value of < 0.00), slight (0.00–0.20), fair (0.21–0.40), moderate (0.41–0.60), substantial (0.61–0.80), and almost perfect (0.81–1.00). The paired t-test and Wilcoxon test were used to compare the preoperative HHS with the HHS at final follow-up, and between-group comparisons were made using the Kruskal–Wallis test. Rate comparisons were performed using the χ2 test. Single risk factor analysis for surgical failure was performed using the Kaplan–Meier method. A P value of < 0.05 was considered statistically significant.
Results
Data from 50 sets of CT or MRI scans were obtained from 37 patients (left hip, n = 14; right hip, n = 10; both hips, n = 13) with a mean age of 39.59 ± 10.70 years. In total, 2,800 evaluations were performed between different observers, and 400 repeatability evaluations were performed between the same observers. The interobserver reliability consistency among different residents according to the 2021 ARCO classification is shown in Table 1. The average kappa value of interobserver consistency was 0.652 (range, 0.422–0.872). The intraobserver repeatability consistency in the same resident between two performances is shown in Table 2. The average rate of consistency was 90.250%, and the average kappa value of intraobserver consistency was 0.836 (range, 0.680–0.934).
At the last follow-up, eight patients (eight hips) were lost to follow-up, and nine patients had traumatic femoral head necrosis. Ultimately, 82 patients (122 hips) were enrolled and followed up for a mean of 43.57 ± 9.64 months. The characteristics of the patients are shown in Table 3. The procedure of the operation is shown in Fig. 1I [17].
The mean preoperative HHS was 79 ± 14, and that at the last follow-up was 81 ± 21 (improvement of 3 ± 25) (P = 0.130). Although the HHS at the last follow-up was better than that before surgery, the difference was not statistically significant (P = 0.130). There was no significant difference in the HHS among the three groups before surgery; however, significant differences were found at the last follow-up, with the highest score in type 1, followed by types 2 and 3, respectively. Among them, types 1 and 2 had significantly higher scores at the last follow-up than preoperatively (P < 0.05), whereas type 3 had a lower score at the last follow-up than preoperatively, although the difference was not statistically significant (P > 0.05)(Table 4).
According to the imaging evaluation, the failure rate of type 1 (Fig. 2), type 2 (Fig. 3), and type 3 (Fig. 4) at the last follow-up was 0% (Success rate: 100%), 19% (Success rate: 82%), and 87% (Success rate: 13%), respectively. The difference in the failure rate among the three groups was statistically significant (P < 0.05). The failure rate of type 2 was significantly higher than that of type 1 (P < 0.05), and that of type 3 was significantly higher than that of types 1 and 2. The univariate analysis showed that the femoral head survival rate was significantly affected by the new ARCO classification system (P = 0.00) (Fig. 5A) (Table 4).
At the last follow-up, the estimated incidence rate of THA in patients with type 1 ONFH was 5%, that in patients with type 2 was 7%, and that in patients with type 3 was 31%. The rate of THA was significantly different among the three groups (P < 0.05). The failure rate of type 2 was significantly higher than that of type 1 (P < 0.05), and that of type 3 was significantly higher than that of types 1 and 2. The univariate analysis showed that the femoral head survival rate was significantly affected by the new ARCO classification system (P = 0.001) (Fig. 5B) (Table 4).
Discussion
ONFH is associated with a high disability rate. Most affected patients are young; however, the long-term effect of THA is uncertain in young people [18, 19]. Therefore, hip preservation therapy is an important method to delay progression of the disease and has been widely studied in recent years [1, 17]. Once ONFH is diagnosed, it should be staged [20]. The purpose of staging is to guide the formulation of a treatment plan, judge the prognosis, and evaluate the treatment efficacy [21]. Thus, accurate evaluation and classification of the size and location of the necrotic area are of utmost importance [15]. Three classification systems are currently in widespread use: the Steinberg classification, the Japanese Investigation Committee classification, and the modified Kerboul classification. However, all three have limitations [13, 22,23,24,25]. Thus, ARCO developed a novel classification system for early-stage ONFH in 2021, and the classification is a highly reliable and valid method [15].
An effective staging method should be simple, effective, reproducible, and clinically instructive. In this study, images were randomly selected and observed by new training residents to determine the interobserver and intraobserver consistency. The average kappa value of interobserver consistency was 0.652, and that of intraobserver consistency was 0.836. According to the standards of Landis and Koch [16], the results showed that 2021 ARCO classification had a substantial degree of consistency and repeatability. We obtained the following four findings through clinical observation. (1) At the last follow-up, the HHS of type 1 and 2 ONFH were significantly higher than those before the operation. Although there was no significant difference in the HHS of type 3 between the preoperative period and the last follow-up, we found that the score tended to decrease after surgery. (2) Type 3 had the highest imaging failure rate at 87%. (3) The rate of THA was also highest in type 3. (4) The single risk factor analysis showed that the 2021 ARCO classification was helpful in predicting the outcome of imaging progression and the incidence of THA.
Koo et al. [15] only observed the imaging changes at different stages of ONFH. The present study is the first to explore the guiding significance of the new staging classification in predicting clinical efficacy after surgery through clinical observation, and it showed that the postoperative efficacy was poor in patients with stage 3. We found that although patients in stage 1 showed no disease progression on imaging, one patient (one hip) underwent THA because of dysfunction. Therefore, the relationship between hip function and imaging needs further study.
The present study has some limitations. First, the surgical outcomes are from a single center. Second, the sample size was small and the follow-up time short. Large sample and long-term follow-up results are thus needed.
Conclusion
The 2021 ARCO classification for early-stage ONFH shows a substantial degree of consistency and repeatability. The new classification can predict the curative effect after femoral head-preserving surgery. Therefore, we do not recommend femoral head-preserving surgery for patients with type 3 ONFH. Future confirmatory studies with larger and different patient cohorts are warranted.
Data Availability
All data and materials used to support the findings of this study are included within the article.
Abbreviations
- ONFH:
-
Osteonecrosis of the femoral head
- ARCO:
-
Association Research Circulation Osseous
- CT:
-
Computed tomography
- MRI:
-
Magnetic resonance imaging
- HHS:
-
Harris hip score
- THA:
-
Total hip arthroplasty
References
Guo P, Gao F, Wang Y, et al. The use of anticoagulants for prevention and treatment of osteonecrosis of the femoral head: a systematic review. Med (Baltim). 2017;96:e6646. https://doi.org/10.1097/MD.0000000000006646.
Kaushik AP, Das A, Cui Q. Osteonecrosis of the femoral head: an update in year 2012. World J Orthop. 2012;3:49–57. https://doi.org/10.5312/wjo.v3.i5.49.
Cui L, Zhuang Q, Lin J, et al. Multicentric epidemiologic study on six thousand three hundred and ninety five cases of femoral head osteonecrosis in China. Int Orthop. 2016;40:267–76. https://doi.org/10.1007/s00264-015-3061-7.
Miranda L, Quaranta M, Oliva F, et al. Maffulli N. Capsular repair vs capsulectomy in total hip arthroplasty. Br Med Bull. 2021;139:36–47. https://doi.org/10.1093/bmb/ldab011.
Hoogervorst P, Campbell JC, Scholz N, et al. Core Decompression and Bone Marrow Aspiration Concentrate Grafting for Osteonecrosis of the femoral head. J Bone Joint Surg Am. 2022;104:54–60. https://doi.org/10.2106/JBJS.20.00527.
Yue J, Guo X, Wang R, et al. Single approach to double-channel core decompression and bone grafting with structural bone support for treating osteonecrosis of the femoral head in different stages. J Orthop Surg Res. 2020;15:198. https://doi.org/10.1186/s13018-020-01717-3.
Homma Y, Masubuchi Y, Shirogane Y, et al. Grafting of autologous concentrated bone marrow processed using a point-of-care device for patients with osteonecrosis of the femoral head: a phase 1 feasibility and safety study. Regen Ther. 2022;20:18–25. https://doi.org/10.1016/j.reth.2022.03.002.
Maus U, Roth A, Tingart M, et al. [S3 Guideline. Part 3: non-traumatic avascular necrosis in adults - Surgical treatment of atraumatic avascular femoral head necrosis in adults]. Z Orthop Unfall. 2015;153:498–507. https://doi.org/10.1055/s-0035-1545902.
Liu L, Gao F, Sun W, et al. Investigating clinical failure of core decompression with autologous bone marrow mononuclear cells grafting for the treatment of non-traumatic osteonecrosis of the femoral head. Int Orthop. 2018;42:1575–83. https://doi.org/10.1007/s00264-018-3918-7.
Cheng EY, Cui Q, Goodman SB, et al. Diagnosis and treatment of femoral head osteonecrosis: a protocol for development of evidence-based clinical practice guidelines. Surg Technol Int. 2021;38:371–8.
Wei QS, Li ZQ, Hong ZN, et al. Predicting Collapse in Osteonecrosis of the femoral Head using a New Method: preserved angles of anterior and lateral femoral head. J Bone Joint Surg Am. 2022;104:47–53. https://doi.org/10.2106/JBJS.20.00507.
Liu LH, Li ZR, Sun W, et al. Reliability and repeatability of the China-Japan Friendship Hospital typing classification for nontraumatic osteonecrosis of the femoral head. J Bone Joint Surg Am. 2022;104:40–6. https://doi.org/10.2106/JBJS.20.00051.
Sugano N, Atsumi T, Ohzono K, et al. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci. 2002;7:601–5. https://doi.org/10.1007/s007760200108.
Mont MA, Zywiel MG, Marker DR, et al. The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review. J Bone Joint Surg Am. 2010;92:2165–70. https://doi.org/10.2106/JBJS.I.00575.
Koo KH, Mont MA, Cui Q, et al. The 2021 Association research circulation Osseous classification for early-stage osteonecrosis of the femoral head to computed tomography-based study. J Arthroplasty. 2022;37:1074–82. https://doi.org/10.1016/j.arth.2022.02.009.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.
Yue J, Guo X, Wang R, et al. Preliminary report of the outcomes and indications of single approach, double-channel core decompression with structural bone support and bone grafting for osteonecrosis of the femoral head. BMC Musculoskelet Disord. 2022;23:198. https://doi.org/10.1186/s12891-022-05149-4.
Yoshizawa T, Yoshioka T, Sugaya H, et al. Total hip Arthroplasty after failed hip-preserving surgery with concentrated autologous bone marrow aspirate transplantation for osteonecrosis of the femoral head: a retrospective study. Indian J Orthop. 2022;56:1251–8. https://doi.org/10.1007/s43465-022-00603-w.
Kim SC, Lim YW, Jo WL, et al. Long-term results of total hip arthroplasty in young patients with osteonecrosis after allogeneic bone marrow transplantation for hematological disease: a Multicenter, Propensity-Matched Cohort Study with a Mean 11-Year Follow-Up. J Arthroplasty. 2021;36:1049–54. https://doi.org/10.1016/j.arth.2020.09.010.
Chughtai M, Piuzzi NS, Khlopas A, et al. An evidence-based guide to the treatment of osteonecrosis of the femoral head. Bone Joint J. 2017;99–B:1267–79. https://doi.org/10.1302/0301-620X.99B10.BJJ-2017-0233.R2.
Mont MA, Cherian JJ, Sierra RJ, et al. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update. J Bone Joint Surg Am. 2015;97:1604–27. https://doi.org/10.2106/JBJS.O.00071.
Ha YC, Jung WH, Kim JR, et al. Prediction of collapse in femoral head osteonecrosis: a modified kerboul method with use of magnetic resonance images. J Bone Joint Surg Am. 2006;88(Suppl 3):35–40. https://doi.org/10.2106/JBJS.F.00535.
Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br. 1995;77:34–41.
Kerboul M, Thomine J, Postel M, et al. The conservative surgical treatment of idiopathic aseptic necrosis of the femoral head. J Bone Joint Surg Br. 1974;56:291–6.
Steinberg ME, Brighton CT, Steinberg DR et al. Treatment of avascular necrosis of the femoral head by a combination of bone grafting, decompression, and electrical stimulation. Clin Orthop Relat Res. (1984):137–53.
Acknowledgements
We thank Nancy Schatken BS, MT (ASCP), from Liwen Bianji, Edanz Group China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
Ju’an Yue collect data and write articles; Xiaozhong Guo invented Single approach to double-channel core decompression and bone grafting with structural bone support (SDBS) and did the surgery; Randong Wang, Bing Li, Qiang Sun, Wangyan Liu, Jiao Chen and Fengnian Zhao were responsible for literature review. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
All procedures performed in studies involving human participants were in accordance with the ethical standards of World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects. All methods were approved by the Ethics Committee of Aviation General Hospital (No: HK2019-01-04). Written informed consent was obtained from all subjects and/or their legal guardian(s).
Consent for publication
Not applicable.
Competing interests
All data and materials used to support the findings of this study are included within the article.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Yue, J., Guo, X., Wang, R. et al. Reliability and repeatability of 2021 ARCO classification and its guiding significance in treatment of nontraumatic osteonecrosis of the femoral head. BMC Musculoskelet Disord 24, 469 (2023). https://doi.org/10.1186/s12891-023-06587-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12891-023-06587-4